Evidence map›Paper›PMID 38933653›Full record

ArticleFrontiers in research metrics and analytics2024

Technical-scientific production and knowledge networks about medicinal plants and herbal medicines in the Amazon.

Nadja Lepsch-Cunha, Vinicius Muraro, Henrique Eduardo Mendonça Nascimento, Alysson Mazoni, Cecília Verónica Nunez, Maria Beatriz Machado Bonacelli

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. BrazilianToxins · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nadja Lepsch-CunhaGeneral Coordination of Research, Training and Extension, National Institute of Amazonian Research - INPA, Manaus, AM, Brazil.
Vinicius MuraroResearch Policy, Department of Business Administration, School of Economics and Management, Lund University, Lund, Sweden.
Henrique Eduardo Mendonça NascimentoCoordination of Biodiversity, National Institute of Amazonian Research - INPA, Manaus, AM, Brazil.
Alysson MazoniDepartment of Science and Technology Policy, Institute of Geosciences, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.
Cecília Verónica NunezTechnology and Innovation Coordination - COTEI, National Institute of Amazonian Research - INPA, Manaus, AM, Brazil.
Maria Beatriz Machado BonacelliDepartment of Science and Technology Policy, Institute of Geosciences, Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This paper explores the role of Brazilian research institutions in the global and national context of study of medicinal plants. Most of these plants have ethnopharmacological use and herbal medicines related to the Amazon. It highlights Brazil's position in scientific production and the importance of Amazonian resources in developing phytomedicines. The study aims to provide an overview of the technical-scientific production of medicinal plants and herbal medicines related to the Amazon, focusing on scientific impact, collaboration, Technology Readiness Level (TRL) of scientific production, and innovation system maturity. Methods: The study employs a comprehensive methodological approach, including data collection from Scopus covering the period from 2002 to 2022. The data was cleaned and analyzed using bibliometric and network analysis techniques. Advanced natural language processing techniques, such as Latent Dirichlet Allocation and Jaccard distance measure, were used for TRL classification. Results: The findings reveal a predominant contribution from Brazilian institutions and authors, with 1,850 publications analyzed. Key areas identified include Pharmacology, Toxicology, Pharmaceuticals, Medicine, and Biochemistry. The study also uncovers various collaborative networks and technological maturity levels, with a significant focus on early-stage development phases. Discussion: The research concludes that Brazilian institutions, particularly those in the Amazon region, play a significant role in the scientific exploration and development of medicinal plants and herbal medicines. Despite this, countries like the USA were proportionally more productive in clinical trial research. The study underscores the potential of Brazil's rich biodiversity and traditional knowledge in the pharmaceutical industry, particularly for neglected diseases. It suggests the need for stronger research systems and international collaboration to leverage these resources for global health benefits.

Indexed as

Amazon traditional medicineBrazilneglected tropical diseasescientometricssocial network analysisS&T planningTechnology Readiness Level

Identifiers

PMID38933653
PMCPMC11199724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.